Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Glaukos Corp
(NY:
GKOS
)
132.89
+2.83 (+2.18%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Glaukos Corp
< Previous
1
2
3
4
5
Next >
Dow Jumps 450 Points; UiPath Shares Slide
September 07, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday.
Via
Benzinga
Dow Up 249 Points, Nasdaq Set To Snap Skid
September 07, 2022
Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book.
Via
Talk Markets
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
September 07, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
Via
Benzinga
Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
September 07, 2022
Via
Benzinga
Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment
August 24, 2022
Via
Benzinga
Glaukos Receives FDA 510(k) Clearance For iStent infinite
August 03, 2022
The U.S.
Via
Benzinga
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
September 07, 2022
Via
Benzinga
What's Going On With Glaukos Shares?
September 07, 2022
Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved...
Via
Benzinga
Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating
August 16, 2022
On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before.
Via
Investor's Business Daily
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 03, 2022
Via
Benzinga
Glaukos: Q2 Earnings Insights
August 03, 2022
Glaukos (NYSE:GKOS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by...
Via
Benzinga
Glaukos: Q4 Earnings Insights
February 22, 2022
Glaukos (NYSE:GKOS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos...
Via
Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
Analyst Ratings For Glaukos
January 19, 2022
Glaukos (NYSE:GKOS) has observed the following analyst ratings within the las...
Via
Benzinga
The 6 Most Aggressive Growth Stocks to Buy in July
July 12, 2022
These are the 6 most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
July 12, 2022
Upgrades
Via
Benzinga
Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View
March 25, 2022
Sight Sciences Inc (NASDAQ: SGHT) has treated the first patient in the TRIDENT trial evaluating OMNI Surgical System compared to Glaukos Corp's (NYSE...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug Biogen...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...
Via
Benzinga
Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety Profile
January 12, 2022
Ophthalmic medical company Glaukos Corporation (NYSE: GKOS) announced data from the Phase 2b trial of iDose TR, a sustained-release travoprost implant. The...
Via
Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Higher; All Eyes On Jobs Report
January 07, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the key jobs data for December. Investors are awaiting earnings results from Acuity Brands,...
Via
Benzinga
5 Stocks To Watch For January 7, 2022
January 07, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Acuity Brands, Inc. (NYSE: AYI) to report quarterly earnings at $2.41 per share on revenue of $...
Via
Benzinga
Glaukos Corp (GKOS) FY 2021 Earnings Call Transcript
November 30, 2021
GKOS earnings call for the period ending November 29, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure
November 11, 2021
The FDA has signed off Sight Sciences Inc's (NASDAQ: SGHT) clinical study to assess investigational higher volume OMNI device to perform canal viscodilation...
Via
Benzinga
Exposures
Product Safety
Glaukos Corp (GKOS) Q3 2021 Earnings Call Transcript
November 07, 2021
GKOS earnings call for the period ending October 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.